SCHEMBL9318677

SCHEMBL9318677

C[S+]([O-])c1ccc(O)c([N+](=O)[O-])c1.Cc1ccc(S)c([N+](=O)[O-])c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.43
CYP3A4 P08684 1/20 0.43
ALDH1A1 P00352 4/20 0.41
GPR35 Q9HC97 3/20 0.41
MAPK1 P28482 2/20 0.41
HPGD P15428 2/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KCNMA1 Q12791 2/20 0.38
MAPT P10636 5/20 0.38
LMNA P02545 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6514054 0.85 TSHR (0.36) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL8159792 0.85 ALDH1A1 (0.55) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL6512352 0.83 TSHR (0.35) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL6512944 0.83 TSHR (0.35) TSHRCYP3A4ALDH1A1GPR35HSD17B10
SCHEMBL6512930 0.83 TSHR (0.35) TSHRCYP3A4ALDH1A1GPR35MAPK1
Zinc Ion SCHEMBL6512360 0.83 TSHR (0.35) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL6512939 0.83 TSHR (0.35) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL306096 0.78 TSHR (0.67) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL6523809 0.78 TSHR (0.67) TSHRCYP3A4ALDH1A1GPR35MAPK1
SCHEMBL6517417 0.77 TSHR (0.64) TSHRCYP3A4ALDH1A1GPR35MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0576603-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA, CONTAINING A 5 ALPHA-REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO. INC. (US) 1994-01-05 EP disclosed